- Head and Neck Tumor Measurement [CMO:0001871] — Any value resulting from the quantification of a morphological or physiological parameter related to tumors of the head and neck, a group of biologically similar cancers that start in the lip, oral cavity, nasal cavity, paranasal sinuses, pharynx, and/or larynx. A tumor is an abnormal growth of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.
- Head Circumference [CMO:0000183] — Total distance around the head of an organism.
- Head Dip Measurement [CMO:0003793] — Any measurable or observable characteristic related to a downward motion of the head which originated, or was undertaken, controlled, or accomplished as a result of an organism's free will or choice.
- Head Morphological Measurement [CMO:0000182] — Morphological measurement of the top most or forward most division of an organism's body usually containing the brain and sense organs.
- Head Movement Measurement [CMO:0003792] — Any measurable or observable characteristic related to the motion of the head which originated, or was undertaken, controlled, or accomplished as a result of an organism's free will or choice.
- Head Temperature [CMO:0001035] — Temperature measured at the surface of or within the head of an experimental subject. Because the temperature of the head/brain can influence neurological measurements, head temperature is or can be considered to be distinct from core body temperature.
- Healthy Glomeruli to Total Glomeruli Ratio [CMO:0003865] — A calculated measurement in which the average number of healthy glomeruli per subject is divided by the average total number of glomeruli per subject with the result presented as a ratio, fraction, quotient or percentage, thus normalizing it to total number of glomeruli.
- Hearing Physiological Measurement [CMO:0002204] —
- Heart Angiotensin I Converting Enzyme 2 Activity Level [CMO:0002740] — Quantitation of the catalytic effect exerted by angiotensin I converting enzyme 2 (ACE2) in a specified sample of heart tissue. ACE2, an ACE homolog, is a zinc-dependent peptidase of the M2-metalloprotease family that is sensitive to chloride ion concentration, is a membrane-bound enzyme that acts as a monocarboxypeptidase, and is an essential regulator of heart function.
- Heart Angiotensin I Converting Enzyme Activity Level [CMO:0002741] — Quantitation of the catalytic effect exerted by angiotensin I converting enzyme (ACE) in a specified sample of heart tissue. ACE is one of the enzymes of the renin-angiotensin system, and catalyzes the conversion of angiotensin I into a physiologically active vasoconstrictor peptide angiotensin II.
- Heart Anterior Wall Thickness [CMO:0000990] — The thickness or depth of the ventral/anterior wall of the heart. The ventral wall is the portion of the heart muscle which is farthest from the spine and closest to the chest wall of the organism.
- Heart Atrium Morphological Measurement [CMO:0000334] — Measurement of the physical form or structure of either the right or the left upper chamber of the heart that receives blood from the veins and forces it into a ventricle.
- Heart Blood Flow Measurement [CMO:0002502] — Any measurement of the movement of blood into, through or out of the heart.
- Heart Contraction Measurement [CMO:0000662] — Any measurement of components of the periodic tightening and loosening of the heart muscle.
- Heart Contraction Pressure [CMO:0000665] — Pressure exerted by the heart muscle in its maximally contracted state.
- Heart Dry Weight [CMO:0000070] — The weight of the heart after desiccation.
- Heart Effluent Enzyme Level [CMO:0000675] — The amount of an enzyme in a specified volume of fluid flowing out of the heart.
- Heart Effluent Lactate Dehydrogenase Activity Level [CMO:0000676] — The amount of lactate dehydrogenase activity measured in a specified volume of fluid flowing out of the heart.
- Heart Effluent Lactate Dehydrogenase Activity Level Normalized to Heart Weight [CMO:0000775] — The activity level of LDH in effluent expressed relative to the weight of the heart; calculated as LDH activity divided by heart wet weight.
- Heart Effluent Measurement [CMO:0000671] — A measurement made on a fluid flowing out of the heart.
- Heart Effluent Volume [CMO:0000672] — The volume of a fluid flowing out of the heart.
- Heart Electrical Conduction Measurement [CMO:0000230] —
- Heart Enzyme Activity Level [CMO:0002739] — Any quantification of the ability of a heart enzyme, i.e. a protein located in the heart that catalyzes chemical reactions of other substances without itself being destroyed or altered upon completion of the reactions, to carry out its specified molecular function.
- Heart Fibrotic Lesion Measurement [CMO:0003740] — Any measurement of a lesion in the heart characterized by an abnormal proliferation of fibrous connective tissue. A lesion is a localized pathological change in structure of an organ or tissue due to injury or disease; especially one that is circumscribed and well defined.
- Heart Free Fatty Acid Level [CMO:0002864] —
- Heart Infarction Area [CMO:0000690] —
- Heart Infarction Measurement [CMO:0000680] — Measurement of an area of necrotic tissue in the heart resulting from a reduction or obstruction of the oxygen supply.
- Heart Infarction Size [CMO:0000684] — Measurement of the area, volume or weight of necrotic tissue in the heart resulting from a reduction or obstruction of the oxygen supply to the heart.
- Heart Infarction Volume [CMO:0001015] —
- Heart Infarction Weight [CMO:0000689] —
- Heart Insulin-like Growth Factor 1 MRNA Level [CMO:0002934] —
- Heart Insulin-like Growth Factor 1 Receptor MRNA Level [CMO:0002940] —
- Heart Interventricular End-diastolic Septal Wall Thickness [CMO:0002791] — The thickness, width or depth of the septal wall of the heart ventricles (that is, the portion of the wall between the left and right ventricles that is shared between the two) at the end of diastole when the heart muscle is maximally relaxed.
- Heart Interventricular End-systolic Septal Wall Thickness [CMO:0002792] — The thickness, width or depth of the septal wall of the heart ventricles (that is, the portion of the wall between the left and right ventricles that is shared between the two) at the end of systole when the heart muscle is maximally contracted.
- Heart Isovolumetric Relaxation Time [CMO:0001482] — The length of time in the cardiac cycle between the closing of the aortic and pulmonic/pulmonary semilunar valves and opening of the atrioventricular (AV) valves marking the beginning of ventricular filling. Used as an indicator of diastolic dysfunction.
- Heart Left Atrium End-diastolic Diameter [CMO:0001486] — The distance between two specified opposite points on the periphery of the left atrium of the heart at the end of diastole, that is, when the left ventricle is maximally dilated, and usually corresponds to the left atrium's smallest diameter.
- Heart Left Atrium End-systolic Diameter [CMO:0001485] — The distance between two specified opposite points on the periphery of the left atrium of the heart at the end of systole, that is, when the left ventricle is maximally contracted, and usually corresponds to the left atrium's largest diameter.
- Heart Left Atrium Fractional Shortening [CMO:0001488] — A calculated measurement corresponding to the ratio or percent reduction in left atrial diameter between end-systole and end-diastole. It is calculated as the left atrium end-systolic diameter (LADs) minus the left atrium end-diastolic diameter (LADd) divided by the left atrium end-systolic diameter (LADs).
- Heart Left Atrium Morphological Measurement [CMO:0001483] — Measurement of the physical form or structure of the left upper chamber of the heart that receives blood from the veins and forces it into the left ventricle.
- Heart Left Atrium Ribonucleic Acid Level [CMO:0003324] —
- Heart Left Atrium Weight to Body Weight Ratio [CMO:0002950] —
- Heart Left Atrium Weight to Tibia Length Ratio [CMO:0003193] —
- Heart Left Ventricle Angiotensin II Level [CMO:0003245] —
- Heart Left Ventricle Anterior Wall Thickness [CMO:0000986] — The thickness or depth of the ventral/anterior wall of the left ventricle of the heart. The ventral/anterior wall is the portion of the muscle enclosing the ventricle which is farthest from the spine and closest to the chest wall of the organism.
- Heart Left Ventricle Bradykinin Level [CMO:0003247] —
- Heart Left Ventricle Deoxyribonucleic Acid Composition Measurement [CMO:0001647] — The amount of deoxyribonucleic acid (DNA), the molecule composed of the sugar deoxyribose, phosphate groups and any combination of the bases adenine, guanine, cytosine, and/or thymine, extracted from or contained in the heart left ventricle, the lower chamber of the left side of the heart (from the perspective of the organism rather than the observer), which pumps oxygenated blood out through the aorta to all the tissues of the body.
- Heart Left Ventricle Deoxyribonucleic Acid Level to Body Weight Ratio [CMO:0001649] — A calculated measurement in which amount of deoxyribonucleic acid (DNA), the molecule composed of the sugar deoxyribose, phosphate groups and any combination of the bases adenine, guanine, cytosine, and/or thymine, extracted from or contained in the heart left ventricle, the lower chamber of the left side of the heart (from the perspective of the organism rather than the observer), which pumps oxygenated blood out through the aorta to all the tissues of the body, is divided by the total weight or heaviness of the body and presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and, by extension, to the size of the organism.
- Heart Left Ventricle Diastolic Volume-axis Intercept [CMO:0002912] — Left ventricle diastolic volume-axis intercept (V0) is determined by the line Ped = Eed(Ved-V0), which is based on linear regression of points determined by iterative calculation of the LV end-diastolic pressure-volume relationship. Ped = end-diastolic pressure, Ved = end-diastolic volume, V0 theoretical volume when no pressure is generated, Eed (end-diastolic elastance, stiffness) is the slope of the EDPVR (LV end-diastolic pressurevolume relationship).
- Heart Left Ventricle Dry Weight [CMO:0000539] —
- Heart Left Ventricle End-diastolic Posterior Wall Thickness [CMO:0002597] — The thickness or depth (i.e. the measurement of the two-dimensional extent of the distance between the inner and outer surfaces) of the dorsal/posterior wall of the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed. The dorsal wall is the portion of the muscle enclosing the ventricle which is closest to the spine and farthest from the chest wall of the organism.
- Heart Left Ventricle End-diastolic Anterior Wall Index [CMO:0002893] —
- Heart Left Ventricle End-diastolic Anterior Wall Thickness [CMO:0002496] — The thickness or depth of the ventral/anterior wall of the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed. The ventral/anterior wall is the portion of the muscle enclosing the ventricle which is farthest from the spine and closest to the chest wall of the organism.
- Heart Left Ventricle End-diastolic Area [CMO:0001191] — A measurement of the extent of a two-dimensional plane through the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed, and usually corresponds to its largest diameter.
- Heart Left Ventricle End-diastolic Diameter [CMO:0000982] — The diameter across the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed, and usually corresponds to its largest diameter.
- Heart Left Ventricle End-diastolic Diameter to Body Weight Ratio [CMO:0003220] — A calculated measurement in which the heart left ventricle end-diastolic internal diameter is divided by the weight of the body, and the result presented as a ratio, fraction, quotient or percentage. Heart left ventricle end-diastolic internal dimension is the diameter across the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed, and usually corresponds to its largest diameter.
- Heart Left Ventricle End-diastolic Diameter to Posterior Wall Thickness Ratio [CMO:0003471] — A calculated measurement in which the heart left ventricle end-diastolic internal diameter is divided by the posterior wall thickness, and the result presented as a ratio, fraction, quotient or percentage. Heart left ventricle end-diastolic internal dimension is the diameter across the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed, and usually corresponds to its largest diameter.
- Heart Left Ventricle End-diastolic Elastance [CMO:0002909] — Left ventricle end-diastolic elastance (Eed) is the estimate of the slope of the line Ped = Eed(Ved-V0), which is based on linear regression of points determined by iterative calculation of the LV end-diastolic pressure-volume relationship.
- Heart Left Ventricle End-diastolic Internal Diameter [CMO:0003376] — The diameter across the inside of the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed, and usually corresponds to its largest diameter.
- Heart Left Ventricle End-diastolic Posterior Wall Index [CMO:0002891] — A calculated measurement in which the heart left ventricle end-diastolic posterior wall thickness is divided by the weight of the body, and the result presented as a ratio, fraction, quotient or percentage.
- Heart Left Ventricle End-systolic Area [CMO:0001192] — A measurement of the extent of a two-dimensional plane through the left ventricle of the heart at the end of systole, that is, when the heart muscle is maximally contracted, and usually corresponds to its smallest diameter.
- Heart Left Ventricle End-systolic Diameter [CMO:0000983] — The diameter across the left ventricle of the heart at the end of systole, that is, when the heart muscle is maximally contracted, and usually corresponds to its smallest diameter.
- Heart Left Ventricle End-systolic Diameter to Body Weight Ratio [CMO:0002869] — A calculated measurement in which the heart left ventricle end-systolic internal diameter is divided by the weight of the body, and the result presented as a ratio, fraction, quotient or percentage.
- Heart Left Ventricle End-systolic Elastance [CMO:0002910] — Left ventricle end-systolic elastance (Ees) is the estimate of the slope of the line Pes = Ees(Ves-V0), which is based on linear regression of points determined by iterative calculation of the LV end-systolic pressure-volume relationship.
- Heart Left Ventricle End-systolic Internal Diameter [CMO:0003851] — The diameter across the inside of the left ventricle of the heart at the end of systole, that is, when the heart muscle is maximally contracted, and usually corresponds to its smallest diameter.
- Heart Left Ventricle End-systolic Posterior Wall Index [CMO:0002867] — A calculated measurement in which the heart left ventricle end-systolic posterior wall thickness is divided by the weight of the body, and the result presented as a ratio, fraction, quotient or percentage.
- Heart Left Ventricle End-systolic Posterior Wall Thickness [CMO:0001840] — The thickness or depth (i.e. the measurement of the two-dimensional extent of the distance between the inner and outer surfaces) of the dorsal/posterior wall of the left ventricle of the heart at the end of systole, that is, when the heart muscle is maximally contracted. The dorsal wall is the portion of the muscle enclosing the ventricle which is closest to the spine and farthest from the chest wall of the organism. The left ventricle is the lower chamber of the left side of the heart, which pumps oxygenated blood out through the aorta to all the tissues of the body.
- Heart Left Ventricle Epinephrine Level [CMO:0003469] — The amount in a specified sample of tissue from the heart left ventricle, of epinephrine, a catecholamine which can act as a neurotransmitter, a stress hormone, a stimulator of the sympathetic nervous system and a vasoconstrictor.
- Heart Left Ventricle Fibrotic Lesion Area Measurement [CMO:0003743] — This is a measurement of the extent of a two-dimensional surface of or plane through a single heart left ventricle fibrotic lesion, or a measurement of the total area occupied by fibrotic lesions in a cross-section of the heart left ventricle.
- Heart Left Ventricle Fibrotic Lesion Measurement [CMO:0003741] — Any measurement of a lesion in the left ventricle of the heart characterized by an abnormal proliferation of fibrous connective tissue. A lesion is a localized pathological change in structure of an organ or tissue due to injury or disease; especially one that is circumscribed and well defined.
- Heart Left Ventricle Fibrotic Lesion Size Measurement [CMO:0003742] — This is any measurement of the physical dimensions, proportions, magnitude, or extent of a lesion in the left ventricle of the heart characterized by an abnormal proliferation of fibrous connective tissue. A lesion is a localized pathological change in structure of an organ or tissue due to injury or disease; especially one that is circumscribed and well defined.
- Heart Left Ventricle Fractional Shortening [CMO:0000985] — A calculated measurement corresponding to the ratio or percent reduction in left ventricular diameter between end-diastole and end-systole. Can be calculated as the left ventricle end-diastolic diameter (LVDd) minus the left ventricle end-systolic diameter (LVSd) divided by the left ventricle end-diastolic diameter (LVDd) with the quotient multiplied by 100, i.e. FS = [(LVDd-LVSd)/LVDd] x 100.
- Heart Left Ventricle Infarction Area [CMO:0000692] —
- Heart Left Ventricle Infarction Area to Total Heart Left Ventricle Area Ratio [CMO:0003243] —
- Heart Left Ventricle Infarction Area to Total Heart Left Ventricle Area Ratio [CMO:0003756] — A calculated measurement in which the area of a heart left ventricle infarction is divided by the total area of the heart left ventricle, and the result presented as a ratio, fraction, quotient or percentage, thus normalizing it to heart left ventricle size and, by extension, to the size of the heart.
- Heart Left Ventricle Infarction Measurement [CMO:0000682] — Measurement of an area of necrotic tissue in the left ventricle of the heart resulting from a reduction or obstruction of the oxygen supply to the heart.
- Heart Left Ventricle Infarction Size [CMO:0000685] — Measurement of the area, volume or weight of necrotic tissue in the heart left ventricle resulting from a reduction or obstruction of the oxygen supply to the heart.
- Heart Left Ventricle Infarction Volume [CMO:0003238] —
- Heart Left Ventricle Infarction Volume to Total Heart Left Ventricle Volume Ratio [CMO:0003239] —
- Heart Left Ventricle Infarction Weight [CMO:0000691] —
- Heart Left Ventricle Infarction Weight to Total Heart Left Ventricle Weight Ratio [CMO:0000695] —
- Heart Left Ventricle Insulin-like Growth Factor 1 MRNA Level [CMO:0002939] —
- Heart Left Ventricle Insulin-like Growth Factor 1 Receptor MRNA Level [CMO:0002942] —
- Heart Left Ventricle Interstitial Angiotensin II Level [CMO:0003246] —
- Heart Left Ventricle Interstitial Angiotensin II Level During A Period of Time [CMO:0003482] — The amount of angiotensin II in the heart left ventricle interstitium measured over a designated period of time. Ang II is considered to be the main effector of the renin-angiotensin system (RAS), has endocrine, autocrine/paracrine, and intracrine hormone activities in the body and acts as a powerful vasoconstrictor.
- Heart Left Ventricle Interstitial Bradykinin Level [CMO:0003248] —
- Heart Left Ventricle Interstitial Bradykinin Level During A Period of Time [CMO:0003481] — The amount of bradykinin collected from the intercellular spaces of the left ventricle myocardium over a designated period of time.
- Heart Left Ventricle Interstitial Epinephrine Level [CMO:0003249] —
- Heart Left Ventricle Interstitial Epinephrine Level During A Period of Time [CMO:0003483] —
- Heart Left Ventricle Interstitial Fibrotic Lesion Area to Total Heart Left Ventricule Area Ratio [CMO:0003745] — This is a calculated value in which the extent of the two-dimensional surface occupied by interstitial fibrotic lesions is divided by the total extent of the two-dimensional surface of the heart left ventricle and presented as a ratio, fraction, quotient or percentage, thus normalizing it to the size of the heart left ventricle.
- Heart Left Ventricle Interstitial Norepinephrine Level [CMO:0003250] —
- Heart Left Ventricle Interstitial Norepinephrine Level During A Period of Time [CMO:0003484] —
- Heart Left Ventricle Molecular Composition Measurement [CMO:0002164] — Any quantitation of the molecules, atoms and/or ions which constitute the chemical make-up of the tissue(s) of the heart left ventricle. A molecule is an aggregation of atoms, specifically a chemical combination of two or more atoms forming a specific chemical substance.
- Heart Left Ventricle Morphological Measurement [CMO:0000951] — Any measurement of the physical form or structure of the left ventricle of the heart. The left ventricle is the lower chamber of the left side of the heart, which pumps oxygenated blood out through the aorta to all the tissues of the body.
- Heart Left Ventricle Natriuretic Peptide A Level [CMO:0002165] — The amount in a specified sample of tissue from the heart left ventricle, of natriuretic peptide A (NPPA), a powerful vasodilator and peptide hormone secreted mainly by heart muscle cells and involved in control of extracellular fluid volume and electrolyte homeostasis.
- Heart Left Ventricle Norepinephrine Level [CMO:0003470] — The amount in a specified sample of tissue from the heart left ventricle, of norepinephrine, a catecholamine neurotransmitter and stress hormone with multiple physiological roles including affects on heart rate, blood pressure and vascular tone.
- Heart Left Ventricle Perivascular Fibrotic Lesion Area to Total Heart Left Ventricule Area Ratio [CMO:0003746] — This is calculated value in which the extent of the two-dimensional surface occupied by perivascular fibrotic lesions is divided by the total extent of the two-dimensional surface of the heart left ventricle and presented as a ratio, fraction, quotient or percentage, thus normalizing it to the size of the heart left ventricle.
- Heart Left Ventricle Plus Septum Weight to Body Weight Ratio [CMO:0003869] — A calculated value in which sum of the weight of the left ventricle and the weight of the interventricular septum is divided by the total weight of the body with the result presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and by extension to the size of the organism.
- Heart Left Ventricle Plus Septum Wet Weight [CMO:0003400] — The weight of the lower left chamber of the heart (including the ventricular septum), which pumps oxygenated blood through the aorta into the systemic arteries, after removal from the body and separation from the rest of the heart but without desiccation.
- Heart Left Ventricle Posterior Wall Thickness [CMO:0000239] — The thickness or depth (i.e. the measurement of the two-dimensional extent of the distance between the inner and outer surfaces) of the dorsal/posterior wall of the left ventricle of the heart. The dorsal wall is the portion of the muscle enclosing the ventricle which is closest to the spine and farthest from the chest wall of the organism. The left ventricle is the lower chamber of the left side of the heart, which pumps oxygenated blood out through the aorta to all the tissues of the body.
- Heart Left Ventricle Relative Wall Thickness [CMO:0000988] — A calculated measurement of left ventricular geometry. It is calculated by dividing the end-diastolic diameter into 2x the posterior wall thickness or into the sum of the posterior and septal wall thicknesses. It represents a measure of the wall thickness normalized to the size of the ventricle lumen.
- Heart Left Ventricle Ribonucleic Acid Level [CMO:0002935] —
- Heart Left Ventricle Systolic Volume-axis Intercept [CMO:0002913] — Left ventricle systolic volume-axis intercept (V0) is determined by the line Pes = Ees(Ves-V0), which is based on linear regression of points determined by iterative calculation of the LV end-diastolic pressurevolume relationship. Pes = end-systolic pressure, Ves = end-systolic volume, V0 theoretical volume when no pressure is generated, Ees (index of LV systolic function, contractility) is the slope of the ESPVR (LV end-systolic pressurevolume relationship).
- Heart Left Ventricle Weight [CMO:0000776] —
- Heart Left Ventricle Weight to Body Weight Ratio [CMO:0000530] — A calculated value in which the weight of the left ventricle, the lower chamber of the left side of the heart, which pumps oxygenated blood out through the aorta to all the tissues of the body, is divided by the total weight of the body and the result presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and by extension to the size of the organism.
- Heart Left Ventricle Weight to Heart Left Ventricle End-diastolic Area Ratio [CMO:0002497] — A calculated measurement in which the weight of the left ventricle of the heart is divided by its area at end-diastole, that is, when the heart muscle is maximally relaxed, and the result presented as a ratio, fraction, quotient or percentage.
- Heart Left Ventricle Weight to Right Ventricle Weight Ratio [CMO:0003210] —
- Heart Left Ventricle Weight to Tibia Length Ratio [CMO:0002787] — A calculated value in which the weight of the heart left ventricle is divided by the length of the tibia (the medial and larger of the two bones of the lower leg of bipeds or hindlimb of quadrupeds which articulates with the femur, fibula, and talus), and the result is presented as a ratio, fraction, quotient or percentage,thus normalizing it to the length of the leg and, by extension, to the size of the body.
- Heart Left Ventricle Wet Weight [CMO:0000071] — The weight of the lower left chamber of the heart, which pumps oxygenated blood through the aorta into the systemic arteries, after removal from the body and separation from the rest of the heart but without desiccation.
- Heart Left Ventricular End-diastolic Blood Pressure to Heart Left Ventricular End-diastolic Diameter Ratio [CMO:0002993] —
- Heart Lesion Measurement [CMO:0000678] — A measurement of any lesion of the heart. A lesion is a localized pathological change in structure of an organ or tissue due to injury or disease; especially one that is circumscribed and well defined.
- Heart Measurement [CMO:0000670] —
- Heart Molecular Composition Measurement [CMO:0002863] —
- Heart Morphological Measurement [CMO:0000016] — A measurement of the physical form or structure of the heart, the chambered, muscular organ in vertebrates that pumps blood received from the veins into the arteries, thereby maintaining the flow of blood through the entire circulatory system.
- Heart Non-tumorous Lesion Measurement [CMO:0000861] — Measurement of a heart lesion which is not neoplastic in origin. A lesion is a localized pathological change in structure of an organ or tissue due to injury or disease; especially one that is circumscribed and well defined. Examples of non-tumorous lesions would include wounds, sores, ulcers, infarctions, etc.
- Heart Nucleic Acid Measurement [CMO:0002932] —
- Heart Posterior Wall Thickness [CMO:0000238] — The thickness or depth of the dorsal/posterior wall of the heart. The dorsal wall is the portion of the heart muscle which is closest to the spine and farthest from the chest wall of the organism.
- Heart Protein Activity Measurement [CMO:0002738] — Any quantification of the ability of a protein of the heart to accomplish an effect, e.g. take part in a chemical reaction or carry out a specified molecular function.
- Heart Rate [CMO:0000002] — The number of contractions of the cardiac ventricles per unit of time.
- Heart Rate Variability [CMO:0002812] — Heart rate variability (HRV) is the physiological phenomenon of variation in the time interval between heartbeats. It is measured by the variation in the beat-to-beat interval.
- Heart Rate-corrected Left Ventricular Isovolumetric Relaxation Time [CMO:0002553] — A calculated measurement in which the value of the left ventricular isovolumetric relaxation time is corrected by the square root of the R-R interval [IVRT/(RR)1/2] on a simultaneously-recorded ECG.
- Heart Relative Wall Thickness [CMO:0000992] —
- Heart Ribonucleic Acid Composition Measurement [CMO:0002933] —
- Heart Right Atrium Morphological Measurement [CMO:0001484] — Measurement of the physical form or structure of the right upper chamber of the heart that receives blood from the veins and forces it into the right ventricle.
- Heart Right Atrium Ribonucleic Acid Level [CMO:0003984] — This is a measurement of the amount of ribonucleic acid (RNA), the molecule composed of the sugar ribose, phosphate groups and any combination of the bases adenine, guanine, cytosine, and/or uracil, extracted from or contained in the heart right atrium, the upper chamber of the right side of the heart, which receives deoxygenated blood from the venae cavae and the coronary sinus, and pumps it into the right ventricle through the tricuspid valve.
- Heart Right Atrium Weight to Body Weight Ratio [CMO:0002952] —
- Heart Right Atrium Weight to Left Atrium Weight Ratio [CMO:0003191] —
- Heart Right Atrium Weight to Tibia Length Ratio [CMO:0003192] —
- Heart Right Ventricle Anterior Wall Thickness [CMO:0000996] — The thickness or depth of the ventral/anterior wall of the right ventricle of the heart. The ventral wall is the portion of the muscle enclosing the ventricle which is farthest from the spine and closest to the chest wall of the organism.
- Heart Right Ventricle Deoxyribonucleic Acid Composition Measurement [CMO:0001650] — The amount of deoxyribonucleic acid (DNA), the molecule composed of the sugar deoxyribose, phosphate groups and any combination of the bases adenine, guanine, cytosine, and/or thymine, extracted from or contained in the heart right ventricle, the lower chamber of the right side of the heart (from the perspective of the organism rather than the observer), which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung.
- Heart Right Ventricle Deoxyribonucleic Acid Level to Body Weight Ratio [CMO:0001652] — A calculated measurement in which amount of deoxyribonucleic acid (DNA), the molecule composed of the sugar deoxyribose, phosphate groups and any combination of the bases adenine, guanine, cytosine, and/or thymine, extracted from or contained in the heart right ventricle, the lower chamber of the right side of the heart (from the perspective of the organism rather than the observer), which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung, is divided by the total weight or heaviness of the body and presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and, by extension, to the size of the organism.
- Heart Right Ventricle Dry Weight [CMO:0000656] —
- Heart Right Ventricle Insulin-like Growth Factor 1 MRNA Level [CMO:0002936] —
- Heart Right Ventricle Insulin-like Growth Factor 1 Receptor MRNA Level [CMO:0002941] —
- Heart Right Ventricle Molecular Composition Measurement [CMO:0002938] —
- Heart Right Ventricle Morphological Measurement [CMO:0000952] — Any measurement of the physical form or structure of the right ventricle of the heart. The right ventricle is the lower chamber of the right side of the heart (from the perspective of the organism rather than the observer), which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung.
- Heart Right Ventricle Posterior Wall Thickness [CMO:0000240] — The thickness or depth of the dorsal/posterior wall of the right ventricle of the heart. The dorsal wall is the portion of the muscle enclosing the ventricle which is closest to the spine and farthest from the chest wall of the organism.
- Heart Right Ventricle Ribonucleic Acid Level [CMO:0002937] —
- Heart Right Ventricle Weight [CMO:0000777] —
- Heart Right Ventricle Weight as A Percentage of Body Weight [CMO:0000915] — A calculated value in which the weight of the right ventricle, the lower chamber of the right side of the heart, which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung, is presented as percentage of the total weight of the body thus normalizing it to body weight.
- Heart Right Ventricle Weight to Body Weight Ratio [CMO:0000914] — A calculated value in which the weight of the right ventricle, the lower chamber of the right side of the heart, which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung, is divided by the total weight of the body and presented as a ratio thus normalizing it to body weight.
- Heart Right Ventricle Weight to Left Ventricle Plus Septum Weight Ratio [CMO:0003280] — A calculated value which compares the weight of the right ventricle, the lower chamber of the right side of the heart, which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung, with the weight of the left ventricle (including the ventricular septum), the lower chamber of the left side of the heart, which pumps oxygenated blood out through the aorta to all the tissues of the body, and presents it as a ratio.
- Heart Right Ventricle Weight to Left Ventricle Weight Ratio [CMO:0000108] — A calculated value which compares the weight of the right ventricle, the lower chamber of the right side of the heart, which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung, with the weight of the left ventricle, the lower chamber of the left side of the heart, which pumps oxygenated blood out through the aorta to all the tissues of the body, and presents it as a ratio.
- Heart Right Ventricle Weight to Tibia Length Ratio [CMO:0003188] —
- Heart Right Ventricle Wet Weight [CMO:0000072] — The weight of the lower right chamber of the heart, which pumps venous blood through the pulmonary trunk and arteries to the capillaries of the lung, after removal from the body and separation from the rest of the heart but without desiccation.
- Heart Septum Weight [CMO:0002953] —
- Heart Triglyceride Level [CMO:0002865] —
- Heart Tumorous Lesion Measurement [CMO:0000865] — Measurement of a lesion of the heart which is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors, preneoplastic lesions, and hyperplastic lesions composed of histologically normal cells.
- Heart Ventricle End-diastolic Septal Wall Index [CMO:0002895] — A calculated measurement in which the heart ventricle end-diastolic septal wall thickness is divided by the weight of the body, and the result presented as a ratio, fraction, quotient or percentage.
- Heart Ventricle End-systolic Septal Wall Index [CMO:0002871] — A calculated measurement in which the heart ventricle end-systolic septal wall thickness is divided by the weight of the body, and the result presented as a ratio, fraction, quotient or percentage.
- Heart Ventricle Morphological Measurement [CMO:0000339] — Any measurement of the physical form or structure of one or both ventricles of the heart, that is, the lower chambers of the heart that pump blood away from the heart either to the lungs to be oxygenated or, once oxygenated, to the rest of the body.
- Heart Ventricle Relative Wall Thickness [CMO:0000993] —
- Heart Ventricle Septal Wall Thickness [CMO:0000987] — The thickness or depth of the septal wall of the heart ventricles. The septal wall is the portion of the heart left ventricle ventral/anterior wall and right ventricle dorsal/posterior wall which is shared between the ventricles.
- Heart Ventricle Weight [CMO:0000688] — The heaviness of one or both ventricles of the heart, that is, the lower chambers of the heart that pump blood away from the heart either to the lungs to be oxygenated or, once oxygenated, to the rest of the body, or the degree to which one or both ventricles of the heart are drawn toward the earth by gravity.
- Heart Wall Thickness [CMO:0000236] —
- Heart Weight [CMO:0000017] — The heaviness of the heart (the central cardiac muscle which maintains the circulation of the blood) or the degree to which it is drawn to the earth by gravity.
- Heart Weight to Body Weight Ratio [CMO:0000074] — A calculated value in which the weight of the heart, the chambered, muscular organ in vertebrates that pumps blood received from the veins into the arteries, thereby maintaining the flow of blood through the entire circulatory system, is divided by the total weight of the body, and the result presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and, by extension, to the size of the organism.
- Heart Weight to Tibia Length Ratio [CMO:0001198] — A calculated value in which the weight of the heart, the chambered, muscular organ that maintains the circulation of the blood, is divided by the length of the tibia, the inner and larger bone of the lower leg or hindlimb, and presented as a ratio, fraction, quotient or percentage, thus normalizing it to the length of the leg and, by extension, to the length of the body.
- Heart Wet Weight [CMO:0000069] — The weight of the heart after removal from the body but without desiccation.
- Heart Wet Weight to Body Weight Ratio [CMO:0002408] — A calculated value in which the weight of the heart after removal from the body but without dessication is divided by the total weight of the body, and the result presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and, by extension, to the size of the organism.
- Hematocrit [CMO:0000037] — Percentage of total blood volume that is made up of red blood cells.
- Hematopoietic System Ribonucleic Acid Composition Measurement [CMO:0003361] —
- Hematuria Incidence/prevalence Measurement [CMO:0001202] — Any measurement in which the number of individuals in a study population that display hematuria, that is, blood in the urine, at a point in time or develop hematuria within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
- Hemoglobin Absorbance [CMO:0000507] — The optical density as calculated from the intensity of light at a specified wavelength as it passes through a solution of lysed red blood cells.
- Hemoglobin Distribution Width [CMO:0003022] — The distribution width of erythrocytes by their cellular (individual) hemoglobin concentrations. It is a measurement of the heterogeneity of the red cell hemoglobin concentration.
- Hemoglobin Measurement [CMO:0000508] — A measure of the oxygen carrying pigment of erythrocytes.
- Hepatic Extraction Fraction [CMO:0003846] — This is the fraction of a drug entering the liver from the blood which is irreversibly removed (extracted) during one pass of the blood through the liver. The hepatic extraction fraction (HEF) depends on the hepatic blood flow, uptake into hepatocytes, and enzyme metabolism. HEF can be calculated using deconvolution analysis of the liver using scintigraphic data.
- Hepatocellular Carcinoma Incidence/prevalence Measurement [CMO:0002603] — Any measurement in which the number of individuals in a study population that display hepatocellular carcinoma at a point in time or develop hepatocellular carcinoma within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Hepatocellular carcinomas (HCC) are primary malignant neoplasms of hepatocytes, epithelial liver cells which perform the functions of the liver such as transformation of carbohydrates, synthesis of cholesterol, bile salts and phospholipids, detoxification of exogenous substances, etc. HCC is often associated with cirrhosis and hepatitis B and/or C infection.
- Hepatocellular Carcinoma Tumor Number [CMO:0002600] — A value or quantity determined by count of hepatocellular carcinoma tumors in the liver or in a specified sample of liver tissue, i.e. growths that result from uncontrolled, progressive multiplication of cells, that serve no physiological function, and that display the properties of anaplasia, invasiveness and metastasis. Hepatocellular carcinomas (HCC) are primary malignant neoplasms of hepatocytes, epithelial liver cells which perform the functions of the liver such as transformation of carbohydrates, synthesis of cholesterol, bile salts and phospholipids, detoxification of exogenous substances, etc. HCC is often associated with cirrhosis and hepatitis B and/or C infection.
- Hepatocyte Count [CMO:0000318] — The number of hepatic cells, polyhedral epithelial cells that constitute the substance of a liver acinus, in a specified sample size.
- Herpes Simplex Encephalitis Incidence/prevalence Measurement [CMO:0002368] — Any measurement in which the number of individuals in a study population that display encephalitis resulting from a herpes simplex virus (HSV) infection at a point in time or develop HSV encephalitis within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. HSV encephalitis is an acute (or rarely chronic) inflammatory process of the brain caused by Simplexvirus infections which may be fatal.
- Herpes Simplex Encephalitis Onset/diagnosis Measurement [CMO:0002372] — Any measurement which expresses a quantity related to the beginning, early stages or development of herpes simplex (HSV) encephalitis, or to the official determination of HSV encephalitis as the cause of the observed symptom(s). HSV-induced encephalitis is an acute (or rarely chronic) inflammatory process of the brain caused by Simplexvirus infections which may be fatal.
- Hind Foot Morphological Measurement [CMO:0001948] — Any measurement of the physical form or structure of the most distal portion of the hind leg of a quadruped, i.e., the segment of the hind leg upon which an individual stands and walks.
- Hind Foot Phalanges Count [CMO:0001949] — Ennumeration of the bones of the toes, that is, the digits that form the most distal portion, of the hind foot of a quadruped.
- Hind Limb Length [CMO:0000189] — This is a measurement of the linear extent from end to end of a posterior appendage such as a leg. Typically this means the sum of the length of the femur plus the length of the tibia.
- Hind Limb Morphological Measurement [CMO:0000388] — Measurement of the physical form or structure of a posterior appendage such as a leg or the homologous structure in other animals. In quadrupeds, the appendage(s) farthest from the head of the animal.
- Hind Limb Weight [CMO:0001494] — Measurement of the heaviness of a posterior appendage such as a leg.
- Hindbrain Ribonucleic Acid Composition Measurement [CMO:0003363] —
- Hindbrain Without Cerebellum Ribonucleic Acid Composition Measurement [CMO:0003373] —
- Hip Circumference [CMO:0000014] — Total distance around the body at the region of the body lateral to and including the hip joint or coxa.
- Hippocampal Formation Ribonucleic Acid Composition Measurement [CMO:0003303] —
- Hippocampus Proper Ribonucleic Acid Composition Measurement [CMO:0003365] —
- Homeostatic Model Assessment of Beta Cell Function [CMO:0003211] — Homeostatic model assessment (HOMA-Beta) is a method for assessing β-cell function from basal (fasting) glucose and insulin or C-peptide concentrations. The empirical formulae: HOMA-Beta = 20 x fasting insulin (uU/mL) /[fasting glycemia (mmol=L)- 3.5]
- Homeostatic Model Assessment of Insulin Resistance [CMO:0003002] — Calculated model of insulin resistance where the product of fasting glucose and fasting insulin is divided by 22.5. Glucose is measured in mmol/L and insulin in measured in uIU/ml.
- Horizontal Distance Covered Resulting from Voluntary Locomotion in Proximity to the Target in An Experimental Apparatus to Total Horizontal Distance Covered Ratio [CMO:0002813] —
- Horn Circumference [CMO:0001370] — Distance measured around the base of the pointed projections, often found in pairs, on the head of an animal.
- Horn Length [CMO:0001369] — Length from base to tip of the pointed projections, often found in pairs, on the head of an animal.
- Horn Morphological Measurement [CMO:0001366] — Any measurement of the physical form or structure of one or more horns of an animal. A horn is a usually pointed projection of skin on the head of various animals consisting of a covering of keratin and other proteins surrounding a core of live bone.
- Horn Number [CMO:0000468] — Number of horns, pointed projections often found in pairs, on the head of an individual animal.
- Humerus Area [CMO:0001380] — A measurement of the extent of a two-dimensional surface of or plane through the bone in the upper portion of the forelimb that articulates with the scapula above and the radius and ulna below.
- Humerus Length [CMO:0000469] — Distance from end to end of the humerus, the bone in the upper portion of the forelimb.
- Humerus Morphological Measurement [CMO:0001379] — Any measurement of the physical form or structure of the humerus, the bone in the upper portion of the forelimb that articulates with the scapula above and the radius and ulna below.
- Hydrocephalus Severity Measurement [CMO:0001880] — Any measurement of the degree to which the presentation of hydrocephalus has caused damage to the brain and/or taken over or interfered with the normal functioning of the body as a whole, or specifically of the central nervous system of an organism. Hydrocephalus is a congenital or acquired condition marked by dilatation of the cerebral ventricles, usually occurring secondarily to obstruction of the cerebrospinal fluid pathways, and accompanied by an accumulation of cerebrospinal fluid within the skull.
- Hydrocephalus Severity Score [CMO:0001881] — A quantitative assessment of the degree to which the presentation of hydrocephalus has caused damage to the brain and/or taken over or interfered with the normal functioning of the body as a whole, or specifically of the central nervous system of an organism, for example based on the number of dilated cerebral ventricles and degree to which they are dilated. Hydrocephalus is a congenital or acquired condition marked by dilatation of the cerebral ventricles, usually occurring secondarily to obstruction of the cerebrospinal fluid pathways, and accompanied by an accumulation of cerebrospinal fluid within the skull.
- Hydronephrosis Severity Measurement [CMO:0001207] — Any measurement of the degree to which the presentation of the hydronephrosis disease state, i.e. dilation of the pelvis and calices of one or both kidneys because of the accumulation of urine resulting from obstruction to urine outflow, causes pain or damage.
- Hydronephrosis Severity Score [CMO:0001208] — A calculated measurement of hydronephrosis severity which is derived from a combination of multiple measurements and/or objective or subjective assessments of severity, that is, the degree to which the hydronephrosis disease state causes pain or damage, according to a specified formula or set of criteria.
- Hypothalamus 5-HIAA Level [CMO:0003104] —
- Hypothalamus DOPAC Level [CMO:0003105] —
- Hypothalamus Dopamine Level [CMO:0003106] —
- Hypothalamus HVA Level [CMO:0003236] —
- Hypothalamus Norepinephrine Level [CMO:0003107] —
- Hypothalamus Ribonucleic Acid Composition Measurement [CMO:0003930] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) of which the tissue of the hypothalamus is formed or composed.
- Hypothalamus Serotonin Level [CMO:0003235] —
- Hypoxia-induced Blood Vessel Dilation Expressed as Percent Reduction of the Force Generated in A Pre-constricted Blood Vessel [CMO:0000733] — This is a measure of the relaxation caused by hypoxia on a pre-constricted blood vessel. It is the ratio of the amount of dilation compared to a fully dilated blood vessel.
Data returned: 203 terms all with first letter "H".
Data updated: Sep 01, 2024